3288 results for «2026年4月7日至2026年4月16日002309主力资金流向情况»
3288 results
Is angio-based FFR ready to replace invasive FFR?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Joost Daemen and Ziad Ali in order to know more about physiological assessment in the cathlab and angio-based vFFR, the results of the multicentre vFFR clinical trial, and the future of angio-based FFR in the cathlab.
The latest on the prevail drug-coated balloon
18 May 2021 – From EuroPCR 2021
Watch this session presented by Azeem Latib and Antonio Colombo in order to reflect on the latest information on Prevail DCB and study, to explore DCB technology and hear the expert-recommended indications, and to gain insights through an interesting PI case using Prevail DCB.
PCR Valves e-Course 2020: Opening Ceremony
22 Nov 2020 – From PCR Valves e-Course 2020
Get a feel of the positive vibrations at #PCRvalves by watching a recording of the Opening ceremony, which was broadcast live from 3 TV studios in London, Paris and Toulouse! It shares how the comprehensive and innovative 3-day e-Course on the 3 valves – aortic, mitral...
SELUTION DeNovo study: powered to change medical practice
18 May 2021 – From EuroPCR 2021
Watch this session presented by Christian Spaulding in order to gain insight into how the SELUTION DeNovo study could change medical practice, to understand the strategy and what differentiates the SELUTION DeNovo study, and to learn about the study design and key milestones.
The future and vision of intravascular imaging
18 May 2021 – From EuroPCR 2021
Watch this session presented by Nieves Gonzalo in order to highlight the benefits and future of intravascular imaging, to share the benefits of using a structured and streamlined workflow, MLD-MAX, and to understand the benefits of using AI during the crucial steps of PCI.
The future of PCI seems bright - The MagicTouch sirolimus-coated balloon
18 May 2021 – From EuroPCR 2021
Watch this session presented by Antonio Colombo, Bernardo Cortese and Sandeep Basavarajaiah in order to understand the strategy behind using a DCB as a proper solution for CAD and the result and potential of using a Sirolimus DCB in coronary intervention, as well as to get insights into real...
Next-Generation Structural Heart Pipeline
18 May 2021 – From EuroPCR 2021
Watch this session presented by Jeffrey Popma and Eberhard Grube to learn more about next-generation Structural Heart Pipeline.
Leading dose solutions for your interventions
18 May 2021 – From EuroPCR 2021
Watch this session presented by Laurent Fieldman in order to understand how innovations can help you optimising dose in your procedures, to learn about latest dose reduction tools for complex interventions, and to review expert perspective on using innovative dose reduction tools.
30 years of Rotary ablation
18 May 2021 – From EuroPCR 2021
Watch this session presented by Maurice Buchbinder to learn all about the history of rotary ablation, from its invention 30 years ago to its current practice, and discover various cases highlighting the results of this therapy.
EBC MAIN overview and the impact on clinical practice
18 May 2021 – From EuroPCR 2021
Watch this session presented by David Hildick-Smith, Jens Flensted Lassen and Goran Stankovic in order to learn more about this important study and understand the impact to clinical practice, to gain insights from an interesting EBC main case, and to listen to the expert's perspectives on other recent...
EuroPCR 2021 Hotlines / Late-Breaking Trials: CENTURY JSV, SORT OUT IX, OUTDES, Epic02-RANGO, PIONEER III, and more!
26 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in stents:
- First machine learning derived risk score for target lesion failure
- Ultrathin versus Conventional Second-Generation DES: Meta-Analysis of RCTs
- Five-year outcomes after coronary stenting of small vessels - CENTURY JSV study
- 2-year outcomes of the randomized SORT OUT IX Trial
- Outcomes of...
Revascularisation for chronic coronary syndrome and multivessel disease (Part 1) - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation, to appraise how to select the optimal revascularisation strategy in such patients and to learn how to perform state-of-the-art PCI to achieve optimal procedural outcomes.
This session was originally presented...
Revascularisation for chronic coronary syndrome and multivessel disease - Part 2
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation and to appraise how to select the optimal revascularisation strategy in such patients.
This session was originally presented during EuroPCR 2021.
The PASCAL platform: successfully and confidently treating MR
18 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas van Mieghem, Fabien Praz and Peter Lüdike in order to learn about the PASCAL platform and its differentiated features, to discuss how to identify patients for the treatment with the PASCAL platform, and to review clinical data and discuss patient outcomes...
RADIANCE-HTN TRIO: what does this mean for the treatment of hypertension?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Atul Pathak in order to learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system, and to hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering...
The ability to transform coronary artery disease treatment: innovative nanotechnology-based sirolimus DES and DCB platforms
18 May 2022 – From EuroPCR 2022
Alexandre Abizaid, Marco Valgimigli, Fazila Malik, Luca Testa, Patrick W. Serruys, Damiano Regazzoli, Kumar Prathap, and Sandeep Basavarajaiah take turns in this session to discuss two innovative technologies: a stent platform with nanotechnology and a novel drug-coated balloon (DCB). These novel technologies both have unique features...
How to select three-vessel disease patients eligible for PCI and guide the treatment by angiography-derived physiology
18 May 2022 – From EuroPCR 2022
What is angiographic SYNTAX score? Are 3VD all the same? What do ESC guidelines recommend? You will find answers to these questions, and many more, in this EuroPCR 2022 session, through which you will learn how to identify the right patient for three-vessel PCI, select the lesions to be...
The challenge of the diabetic patient with diffuse coronary artery disease: how physiology can simplify things
18 May 2022 – From EuroPCR 2022
Based on the didactic analysis of several practical cases, and also on the latest guidelines and study outcomes on the subject, learn in this EuroPCR 2022 session new management strategies to optimise PCI in diffuse coronary artery disease, new developments of the Optowire to support decision-making in patients...
Angiography-derived physiological assessment of coronary artery stenosis severity and microvascular dysfunctions
18 May 2022 – From EuroPCR 2022
Follow the demonstrations of this EuroPCR 2022 session to understand the principles, clinical value, and applicability of coronary angiography-derived fractional flow reserve (caFFR), to discuss coronary angiography-derived index of microcirculatory resistance (caIMR) in the assessment of epicardial stenosis and coronary microcirculation, and to review data from available trials supporting these new...
From access to closure in transcatheter valve procedures - Optimising patients' outcomes step by step
18 May 2022 – From EUROPCR 2022
Watch this EuroPCR 2022 session to learn the key steps in transcatheter mitral valve repair and transcatheter aortic valve implantation procedures.
Follow step by step how to optimally access and close venous large bore access sites using suture mediated vessel closure devices, and learn about the key...
